Antinicotinic action of benzyltrimethylammonium bromide (BTM).
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001001:Anura; D001555:Benzene Derivatives / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology; D002645:Chickens; D004336:Drug Antagonism; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology; D009538:Nicotine / Q000037:antagonists & inhibitors*; D011189:Potassium Chloride / Q000037:antagonists & inhibitors; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012584:Sciatic Nerve
D001555:Benzene Derivatives; D001593:Benzyl Compounds; D009467:Neuromuscular Depolarizing Agents; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D011189:Potassium Chloride; D009538:Nicotine; D000109:Acetylcholine